Elliot Stieglitz MD
Pediatric Hematologic Oncology
Associate Professor
Request Appointment
HDFCCC Stieglitz Lab1450 3rd St, Room 283San Francisco, CA 94158
Overview of Dr. Stieglitz
Dr. Elliot Stieglitz is a pediatric hematologist/oncologist in San Francisco, CA and is affiliated with UCSF Medical Center. He received his medical degree from Stony Brook University Health Sciences Center School of Medicine and has been in practice 9 years. He is one of 70 doctors at UCSF Medical Center who specialize in Pediatric Hematology & Oncology. He also speaks multiple languages, including Spanish. He has more than 60 publications and over 500 citings.
Education & Training
University of California (San Francisco)Fellowship, Pediatric Hematology/Oncology, 2011 - 2014
New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2008 - 2011
Stony Brook University Health Sciences Center School of MedicineClass of 2008
Certifications & Licensure
CA State Medical License 2011 - 2026
NY State Medical License 2009 - 2012
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- K08 Clinical Investigator Award NHLBI @ NIH, 2017
- Individual Investigator Award American Cancer Society, 2016
- Rally Grant Rally Foundation for Childhood Cancer Research, 2016
- Join now to see all
Clinical Trials
Publications & Presentations
PubMed
- 1 citationsTargeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR T cells.Corynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar, Amrik S Kang, Nikhil Chilakapati
Blood. 2025-08-14 - Innate immune mechanisms hijacked by leukemia-initiating stem cells for selective advantage and immune evasion in Ptpn11-associated JMML.Hong Zheng, Peng Zhao, Zhenya Tan, Wen-Mei Yu, Juwita Werner
Cell Reports. 2025-07-30 - Multi-selective RAS(ON) Inhibition Targets Oncogenic RAS Mutations and Overcomes RAS/MAPK-Mediated Resistance to FLT3 and BCL2 Inhibitors in Acute Myeloid Leukemia.Bogdan Popescu, Matthew F Jones, Madison Piao, Elaine Tran, Andrew Koh
Biorxiv. 2025-06-14
Journal Articles
- Downregulating Notch Counteracts KrasG12D-Induced ERK Activation and Oxidative Phosphorylation in Myeloproliferative NeoplasmErik A Ranheim, David Yang, Warren S Pear, Lan Zhou, Mignon Loh, Eric Padron, Elliot Stieglitz, Nature
Abstracts/Posters
- DNA Methylation As a Biomarker of Outcome in JMML: An International Effort Towards Clinical ImplementationElliot Stieglitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- In Vitro-Selected Nanobody-Based Cellular Therapy Targeting CD72 for Treatment of Refractory B-Cell MalignanciesElliot Stieglitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
- Promising New Combination of Drugs Identified to Treat Juvenile Myelomonocytic LeukemiaApril 7th, 2023
Baby Diagnosed with Rare Blood Cancer Saved by Miracle TreatmentSeptember 26th, 2019
Infant with Deadly Leukemia Saved by Drug for Adult Liver CancerSeptember 12th, 2019- Join now to see all
Grant Support
- Implementation of an interventional, risk-adapted clinical trial for children with newly diagnosed juvenile myelomonocytic leukemia.UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2022–2027
Other Languages
- Spanish
External Links
- LinkedInhttp://www.linkedin.com/pub/elliot-stieglitz/20/384/870
- Stieglitz Labhttps://www.stieglitzlab.com
- ElliotStieglitz.comhttp://www.elliotstieglitz.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
